Institute for Wealth Management’s Revolution Medicines RVMD Stock Holding History

Institute for Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41K	Buy	+219	New	+$32K	﹤0.01%	925

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return

NNPTE

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return

Institute for Wealth Management's RVMD Position: Q2 2026 in Review

Institute for Wealth Management opened a new position in Revolution Medicines (RVMD) in Q2 2026: 219 shares worth $41K. The stake represents ﹤0.01% of the portfolio and ranks #925 among its holdings.

313 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Institute for Wealth Management held 219 shares of Revolution Medicines worth $41K as of Q2 2026.
Revolution Medicines was a new Institute for Wealth Management position in Q2 2026.
Revolution Medicines made up ﹤0.01% of Institute for Wealth Management's portfolio in Q2 2026, its #925 holding.
313 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.